Sun Pharma Acquires Ranbaxy}
Read An Opinion On: Los Angeles International Tax Accountant Submitted by: M&A Critique In April 2014, Sun Pharmaceutical acquired 100% of Ranbaxy Laboratories for $4 billion to create worlds fifth largest specialty generic pharma company. Under these agreements, Ranbaxy will merge into Sun Pharma and the shareholders of Ranbaxy will receive 0.8 shares of Sun […]